CompuGroup Medical SE & Co. KGaA carries a market capitalization of 1.19B, placing it among publicly traded companies globally. Its enterprise value stands at 1.83B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.19B |
| Enterprise Value | 1.83B |
CompuGroup Medical SE & Co. KGaA currently has 51.73M shares outstanding.
| Shares Outstanding | 51.73M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CompuGroup Medical SE & Co. KGaA trades at a trailing price-to-earnings ratio of 42.06. The price-to-sales ratio is 0.98, and the price-to-book ratio stands at 21.13.
| PE Ratio | 42.06 |
| PS Ratio | 0.98 |
| PB Ratio | 21.13 |
| P/TBV Ratio | -1.65 |
| P/FCF Ratio | 7.94 |
| P/OCF Ratio | 7.89 |
On an enterprise value basis, CompuGroup Medical SE & Co. KGaA trades at an EV/EBITDA multiple of 18.30 and an EV/FCF ratio of 11.33. The EV/Sales ratio of 1.59 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.30 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.59 |
| EV / EBITDA | 18.30 |
| EV / EBIT | 18.30 |
| EV / FCF | 11.33 |
CompuGroup Medical SE & Co. KGaA maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 126.77, indicating elevated leverage, while an interest coverage ratio of 2.98 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.12 |
| Quick Ratio | 0.31 |
| Debt / Equity | 126.77 |
| Debt / EBITDA | 8.25 |
| Interest Coverage | 2.98 |
CompuGroup Medical SE & Co. KGaA posts a return on equity of 50.24 and a return on invested capital of 3.56.
| Return on Equity (ROE) | 50.24 |
| Return on Assets (ROA) | 1.34 |
| Return on Invested Capital (ROIC) | 3.56 |
| Return on Capital Employed (ROCE) | 5.21 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 11.74 |
Over the trailing twelve months, CompuGroup Medical SE & Co. KGaA has paid 23.98M in income taxes, reflecting an effective tax rate of 46.66.
| Income Tax | 23.98M |
| Effective Tax Rate | 46.66 |
CompuGroup Medical SE & Co. KGaA's stock has declined approximately -13.43621% over the past 52 weeks. The 50-day moving average sits at 24.17, while the 200-day moving average is 20.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.43621% |
| 50-Day Moving Average | 24.17 |
| 200-Day Moving Average | 20.73 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CompuGroup Medical SE & Co. KGaA generated 1.16B in revenue and converted that into 27.00M in net income, yielding earnings per share of 0.53. EBITDA reached 100.25M, while operating income came in at 100.25M.
| Revenue | 1.16B |
| Gross Profit | 968.89M |
| Operating Income | 100.25M |
| Pretax Income | 51.40M |
| Net Income | 27.00M |
| EBITDA | 100.25M |
| EBIT | 100.25M |
| Earnings Per Share (EPS) | 0.53 |
CompuGroup Medical SE & Co. KGaA holds 128.64M in cash and equivalents against 826.65M in total debt, resulting in a net debt position of 654.08M. Total book value stands at 53.74M, with working capital of 50.03M providing operational flexibility.
| Cash & Cash Equivalents | 128.64M |
| Total Debt | 826.65M |
| Net Debt | 654.08M |
| Equity (Book Value) | 53.74M |
| Book Value Per Share | 1.04 |
| Working Capital | 50.03M |
CompuGroup Medical SE & Co. KGaA produced 143.96M in operating cash flow over the past twelve months.
| Operating Cash Flow | 143.96M |
| Capital Expenditures | N/A |
| Free Cash Flow | 143.96M |
| FCF Per Share | 2.78 |
CompuGroup Medical SE & Co. KGaA operates with a gross margin of 83.85, reflecting its pricing power and cost economics. The operating margin of 8.68 and net profit margin of 2.34 provide insight into operational efficiency.
| Gross Margin | 83.85 |
| Operating Margin | 8.68 |
| Pretax Margin | 4.45 |
| Profit Margin | 2.34 |
| EBITDA Margin | 8.68 |
The company's payout ratio of 185.88 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.00 |
| Dividend Yield | N/A |
| Payout Ratio | 185.88 |
| Shareholder Yield | 3.14 |
| FCF Yield | 12.59 |
CompuGroup Medical SE & Co. KGaA posts an Altman Z-Score of 2.79, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.79 |